Gemtuzumab ozogamicin
About
Therapy type: Immunotherapy
Therapy strategy: CD33 inhibition
Mappings
NCI Thesaurus: Gemtuzumab Ozogamicin (coding:ncit:C1806)
RxNorm: gemtuzumab ozogamicin (coding:rxcui:1294580, coding:omop:42799711)
SNOMED: Gemtuzumab ozogamicin (coding:sctid:127964000, coding:omop:4027914)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | CD33 + | Acute Lymphoid Leukemia | Gemtuzumab ozogamicin | |
| HC (1) | CD33 + | Acute Myeloid Leukemia | Cytarabine, Daunorubicin, Gemtuzumab ozogamicin |